Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer: A Randomized Controlled Clinical Trial

NCT03651219 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.

NCT NCT03651219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03651219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer: A Randomized Controlled Clinical Trial
Lead sponsor
Beijing Chest Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
September 8, 2018
Completion date
August 8, 2020
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer